Buyout Financing

Blue Coat Announces $1.7B LBO Notes/Loan Offer

The Sunnyvale, Calif.-based enterprise Web security company is marketing both a $1.05 billion term loan, a $100 million revolver and a $570 million, eight-year notes offer to help fund its announced acquisition by Bain Capital from Thomas Bravo.

Sterigenics-Nordian Sets $450M Notes Offer

Sterigenics-Nordian Holdings has followed a recent $1.2 billion loans proposal with a new $450 million bonds offering Wednesday that will help fund the majority-stake purchase made by sponsor Warburg Pincus.

Grocery Outlet Wants New Terms on $450M TLB

Grocery Outlet, a California-based “extreme value” grocery chain bought out by Hellman & Friedman last fall, is looking to reprice a $450 million term loan B it allocated in October to fund the takeover.

Spectrum Plans Debt for $1.4B Armored Acquisition

Spectrum plans to fund the purchase through a combination of new debt backed by Credit Suisse, Deutsche Bank and Jefferies, along with $500 million in Spectrum Brands common stock.

Aspen Dental's Upsized $435M Loan Allocates After Flex

Aspen Dental Management closed on an upsized $435 million loan offering Monday following a price flex that narrowed terms on the facility funding a major investment by middle-market private equity firm American Securities.

Sterigenics-Nordion Launches $1.2B Loan

Sterigenics-Nordion has launched a $1.2 billion loans offering to leverage the major-stake investment that one of its sponsors – Warburg Pincus – announced last month.

Leighton/Apollo JV Sets Up $900M Loans Proposal

A joint venture formed by Australian construction giant Leighton Holdings Ltd. and Apollo Global Management has launched a multi-currency, $900 million-equivalent loans proposal to finance its formation and provide start-up collateral.

Research Now Allocates $435M in Loans

Digital data collection company Research Now Group priced and allocated a package of first- and second-lien loans Wednesday, raising funds to close on its buyout by private equity firm Court Square Partners, according to KDP Investment Advisors.

Valeant Prices Bonds, Loans for Salix Acquisition

Valeant Pharmaceuticals on Friday wrapped $14.15 billion in debt funding for its plans to acquire Salix Pharmaceuticals, despite a rival unsolicited bid by Endo International for Salix that surfaced this week.

Endo's Salix Bid Arrives in Midst of Valeant’s Road Show

Endo International confirmed Wednesday it has submitted an unsolicited $15.7 billion takeover bid for Salix Pharmaceuticals. But Valeant Pharmaceuticals said it planned to stay the course with its $14.5 acquisition agreement with Salix, and is moving forward with bond and loan offerings that hit the market this week to finance the merger.

More

LFN People Database

Exclusive data on top players in capital markets

David Heilbrunn

Managing Director

Firm: Fifth Street Asset Management

In the news: Fifth Street Hires CLO Pro David Heilbrunn

Search the People Database

Data Snapshot